Title: Osteoclast-targeting small molecules for the treatment of neoplastic bone metastases.
Journal: Cancer science 20091101
Title: Inhibition of bone and muscle metastases of lung cancer cells by a decrease in the number of monocytes/macrophages.
Journal: Cancer science 20080801
Title: Pharmacological topics of bone metabolism: antiresorptive microbial compounds that inhibit osteoclast differentiation, function, and survival.
Journal: Journal of pharmacological sciences 20080401
Title: Development and application of bioprobes for Mammalian cell cycle analyses.
Journal: Current medicinal chemistry 20030501
Title: Reveromycin A inhibits antigen receptor-mediated antigen presentation by B lymphoma cells via its effect on intracellular trafficking of the antigen.
Journal: The Journal of antibiotics 20021001
Title: Identification of Saccharomyces cerevisiae isoleucyl-tRNA synthetase as a target of the G1-specific inhibitor Reveromycin A.
Journal: The Journal of biological chemistry 20020809
Title: H Takahashi , et al. Reveromycins, new inhibitors of eukaryotic cell growth. II. Biological activities. J Antibiot (Tokyo). 1992 Sep;45(9):1414-9.
Title: Je-Tae Woo, et al. Reveromycin A, an agent for osteoporosis, inhibits bone resorption by inducing apoptosis specifically in osteoclasts. Proc Natl Acad Sci U S A. 2006 Mar 21;103(12):4729-34.
